MD Learning Channel – Free CME Opportunities

Through a series of case studies, Rachael B. Lancaster, MD, gives an update on breast cancer surgical margins and discusses the recent changes in the landscape.

Smita Bhatia, MD, MPH, discusses the Institute for Cancer Outcomes and Survivorship and the importance of survivorship clinics.

Gabrielle Rocque, MD, and Rodney Tucker, MD, MMM, discuss common late effects seen in cancer patients.

Daniel I. Chu, MD, discusses hereditary colorectal cancers and when you should consider referring your patient for genetic testings.

Greg Kennedy, Ph.D., M.D., an internationally recognized surgeon and researcher, discusses the continuum of research on improving outcomes of colorectal cancer.

Rachael B. Lancaster, MD, discusses the indications and prognosis for neoadjuvant therapy in breast cancer and illustrates these points with case studies.

Gregory D. Kennedy, MD, gives an update on surgical therapies for colorectal cancer and discusses neoadjuvant and adjuvant chemotherapy options.

Thomas N. Wang, MD, PhD, discusses where it is necessary to dissect the lymph node for well-differentiated thyroid cancer.

In part two of his grand rounds lecture, Carlo M. Contreras, MD, FACS, discusses chemotherapy options, the role of surgical lymphatic staging, and estimating prognosis of melanoma.

Carlo M. Contreras, MD, FACS, discusses the benefits of several neoadjuvant treatment options for patients with gastric cancer.

Benjamin Wei, MD, discusses the optimal preoperative evaluation of patients with esophageal cancer, which includes staging the cancer, evaluating the patient, and determining the optimal therapy.

In part one of his grand rounds lecture, Carlo M. Contreras, MD, FACS, discusses how the adequacy of lymphadenectomy has been defined in other gastrointestinal epithelial cancer and how we might apply that to pancreatic cancer through the use of the American College of Surgeons national database.